Brewin Dolphin Wealth Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-26,500	Closed	-$90.1K	–	192
2018 Q3	$90.1K	Hold	26,500	–	–	0.05%	95
2018 Q2	$99.6K	Hold	26,500	–	–	0.06%	92
2018 Q1	$108K	Hold	26,500	–	–	0.07%	88
2017 Q4	$123K	Buy	26,500 +17,500	+194%	+$96.4K	0.08%	82
2017 Q3	$63.9K	Buy	+9,000	New	+$64.7K	0.04%	89

Brewin Dolphin Wealth Management's KERX Position: Q4 2018 in Review

Brewin Dolphin Wealth Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 26,500 shares — an estimated $90.1K sold.

Brewin Dolphin Wealth Management first reported a position in KERX in Q3 2017 and held it in 5 quarters. The position peaked at $123K in Q4 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Brewin Dolphin Wealth Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Brewin Dolphin Wealth Management sold 26,500 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $90.1K.
Brewin Dolphin Wealth Management first reported a position in Keryx Biopharmaceuticals Inc in Q3 2017 and held it in 5 quarters.
Brewin Dolphin Wealth Management's Keryx Biopharmaceuticals Inc position peaked at $123K in Q4 2017.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Brewin Dolphin Wealth Management's 13F filing for Q4 2018, filed 9 Nov 2023.